The Jill Roberts Institute for Research in Inflammatory Bowel Disease

You are here

Randy Longman, M.D., Ph.D.

Assistant Professor of Medicine

I am a gastroenterologist and mucosal immunologist focused on basic research to understand the causes and to develop new therapies for inflammatory bowel diseases (IBD).  Inflammatory bowel disease (IBD) affects over 2 million Americans.  While pharmacologic advances have improved the care of these patients, many still have refractory disease with significant morbidity.  IBD includes two distinct clinical phenotypes called Crohn’s disease and ulcerative colitis.  Genetic polymorphisms correlate with disease susceptibility, but they are rarely fully penetrant reflecting a central role for environmental triggers in disease pathogenesis.  While indeed certain luminal microbes may act as opportunistic pathogens causing infection and inflammation, we and others have shown that microbiota function as a double-edged sword to simultaneously suppress aberrant immune cell activation (homeostatic inhibition) and maintain homeostasis (homeostatic induction) at mucosal surfaces.  Thus, the major focus of our work is to define cellular and molecular regulation of innate intestinal barrier immunity and to harness the power of IBD-associated microbiota to develop novel diagnostic and therapeutic approaches to medically refractory IBD.

Education and Training

  • M.D., Weill Cornell Medical College 2007
  • Ph.D., The Rockefeller University 2006

 

View Recent Publications

 

Grants awarded

Weill Cornell Medicine The Jill Roberts Institute for Research in Inflammatory Bowel Disease 413 E 69th Street, 7th Floor New York, NY 10021 Phone: (646) 962-6312